Our skin specialists can help you achieve your desired look
Our specialist injectors at Complete Skin Specialists offer a revolutionary surgery-free procedure to reduce the fat pocket resulting in a double chin and tighten the skin of the jawline and neck.
The procedure entails a series of injections directly into the submental fat (double chin). Usually a series of 2-4 treatments are required to achieve the desired result, but all improvement is permanent. The procedure can be performed as part of a full face rejuvenation or facial reshaping to restore a more youthful appearance and face shape.
Our highly educated and experienced injectors offer safe, advanced injecting techniques in a private and confidential specialist medical clinic.
What is a double chin reduction?
BELKYRA® is the only non-surgical injectable treatment for reduction of fullness under the chin, known as submental fullness or double chin. It has now been used in clinical trials for 9 years and been shown to be safe and effective.
Before starting treatment, we will examine the area under and around the chin to determine if BELKYRA® is right for you. The treatment is tailored to the amount of fat you have under the chin and your aesthetic goals. Clients with extreme amounts of fat or very lax skin, and those who have had previous surgery in the area may not be suitable for this treatment.
How does it work?
When injected into the fat beneath the chin, BELKYRA® breaks down the fat cells. This causes some inflammation in the area as the body’s immune system clears out the broken-down cells. Fibroblasts (collagen producing cells) then come in to ‘heal’ the area resulting in a noticeable reduction in fullness under the chin and secondary tightening of the skin. Once destroyed, these cells can no longer store or accumulate fat, so further treatment is not expected once you reach your desired aesthetic goal.
What is it made of?
The active ingredient in BELKYRA® is synthetic deoxycholic acid. Deoxycholic acid occurs naturally in the body to aid the breakdown and absorption of dietary fat. It is manufactured by Allergan who also manufacture Botox ® and Juvederm ® fillers.
How many treatments are needed, and what does it cost?
The amount of BELKYRA® product and the number of treatments required varies and depends on the amount of fat, the individual’s anatomy and the desired aesthetic outcome. Most patients require between 2 and 4 treatments and will need 2-3 vials each time.
We advise to space treatments approximately 6-8 weeks apart. Results may not be seen until after the second treatment.
The minimum treatment is a course of 2 treatments, each using 2 vials of product. This is the starting commitment costing $2600 (including GST). Should further vials or treatments be required, the additional cost will be $600 per vial (including GST)
What are the risks and side effects?
Some side effects are expected following treatment.
The treatment is administered via a series of small injections. The number will vary depending on the individual treatment area. Ice is used to reduce sensitivity.
- Significant swelling (approximately doubling of the original size) tends to occur during the first 48 hours after treatment. This is part of the action of the treatment but tends to reduce with subsequent treatments. Some bruising may also occur
- Pain is another common side effect. An internal burning or stinging sensation is commonly experienced within minutes of the treatment. This tends to ease off within 1 hour. Ice or paracetamol can be used if ease discomfort if needed. The area can remain tender for a number of days
- Skin numbness usually occurs over the injection site and, on average takes 6-8 weeks to resolve
- Firmness or lumpiness in the area occurs in some people as the skin tightens (usually between 4 and 6 weeks after treatment)
- Serious side effects have been reported during clinical trials. Temporary nerve injury which can cause an uneven smile occurred in 4% of patients, resolving on average in 44 days. Trouble swallowing occurred in 2% of patients resolving on its own in a median of 3 days
- Refinement of the injecting technique since the clinical trial seems to have decreased the chance of these complications